Iclusig 15 MG
Ended Awarded
- Contract number
- 36C24525N0213
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,957
Award facts
- Contract value 100% obligated
- $13,956.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America, Inc., a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, based in Japan. The contract is for the supply of ICLUSIG 15 MG, a specialty oncology medication used to treat certain types of leukemia. The contract has a firm-fixed-price pricing type and a ceiling value of $13,956.72, with an ultimate completion date of December 10, 2024. This contract award is placed against Takeda's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract does not have a set-aside designation, reflecting Takeda's status as a large, foreign-owned business. This contract award is part of a larger Blanket Purchase Agreement (BPA) that Takeda Pharmaceuticals America holds with the VA National Acquisition Center, valued at over $123.5 million, for the supply of ICLUSIG to VA medical facilities nationwide.
Quick answers
Who was awarded contract 36C24525N0213?
36C24525N0213 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 4, 2024.
How much is contract 36C24525N0213 worth?
The government has obligated $13,957 on 36C24525N0213.
Is contract 36C24525N0213 an order under another contract?
Yes. 36C24525N0213 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0213 competed?
The extent of competition for 36C24525N0213 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award